4-phenylbutyric acid and losartan potassium

4-phenylbutyric acid has been researched along with losartan potassium in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brusilow, SW; Collins, AF; Dover, GJ; Giardina, P; McDonagh, KT; Pearson, HA	1
Coates, TD; Davies, S; Kuypers, FA; Mignacca, R; Olivieri, NF; Singer, ST; Sweeters, N; Vichinsky, EP; Weatherall, DJ	1

Trials

2 trial(s) available for 4-phenylbutyric acid and losartan potassium

Article	Year
Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial. Blood, 1995, Jan-01, Volume: 85, Issue:1 Topics: Adult; Anemia, Sickle Cell; beta-Thalassemia; Blood Transfusion; Erythropoietin; Female; Fetal Hemoglobin; Globins; Hemoglobins; Hemolysis; Homozygote; Humans; Male; Mutation; Patient Compliance; Phenylbutyrates; Reticulocytes	1995
Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. Annals of the New York Academy of Sciences, 2005, Volume: 1054 Topics: beta-Thalassemia; Blood Transfusion; Combined Modality Therapy; Drug Therapy, Combination; Erythropoiesis; Erythropoietin; Facial Bones; Fetal Hemoglobin; Gene Expression; Genotype; Globins; Hematopoiesis, Extramedullary; Hemoglobin E; Humans; Hydroxyurea; Phenylbutyrates; Radiography; Recombinant Proteins; Splenectomy; Splenomegaly; Treatment Outcome	2005

Article

Year

Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial.

Blood, 1995, Jan-01, Volume: 85, Issue:1

Topics: Adult; Anemia, Sickle Cell; beta-Thalassemia; Blood Transfusion; Erythropoietin; Female; Fetal Hemoglobin; Globins; Hemoglobins; Hemolysis; Homozygote; Humans; Male; Mutation; Patient Compliance; Phenylbutyrates; Reticulocytes

1995

Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment.

Annals of the New York Academy of Sciences, 2005, Volume: 1054

Topics: beta-Thalassemia; Blood Transfusion; Combined Modality Therapy; Drug Therapy, Combination; Erythropoiesis; Erythropoietin; Facial Bones; Fetal Hemoglobin; Gene Expression; Genotype; Globins; Hematopoiesis, Extramedullary; Hemoglobin E; Humans; Hydroxyurea; Phenylbutyrates; Radiography; Recombinant Proteins; Splenectomy; Splenomegaly; Treatment Outcome

2005